Durable responses to immunotherapy seen in rare angiosarcoma tumors
In a small study of 16 patients with the rare cancer angiosarcoma, tumors in four patients partially or completely responded
Read more
BCMA-targeted immunotherapy can lead to durable responses in multiple myeloma
An experimental, off-the-shelf immunotherapy that combines a targeted antibody and chemotherapy can lead to potentially durable responses in multiple myeloma
Read more